from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1604/impA

LFCtreatmentdescriptionclass of inhibitor

-1.193

Amikacinug/mL Amikacintranslation

-2.163

Cap5-10ug/mL Capreomycintranslation

-2.113

Rox10-50 ug/mL Roxithromycintranslation

-0.475

SM2-5 ug/mL Streptomycintranslation

-1.582

Tet5-10 ug/mL Tetracyclinetranslation

0.433

Rif0.2-5ug/mL Rifampicintranscription

-0.209

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.265

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.853

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.528

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.464

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.421

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.896

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.088

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.881

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.783

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.667

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.744

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.463

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.721

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.425

KCN5-20 ug/mL Potassium cyaniderespiration

-0.294

NaN30.2-2 mM Sodium aziderespiration

-0.077

Nigericin50 uM Nigericinrespiration

0.870

TRC10-150 ug/mL Triclosanrespiration

-0.133

TRZ10-25 ug/mL Thioridazinerespiration

-0.580

Valinomycin0.5-10 uM Valinomycinrespiration

-1.251

ZnSO42 mM ZnSO4respiration

0.882

menadione6-10 ug/mL Menadionerespiration

-0.656

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.615

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.469

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.397

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.448

NRP_1Non-replicating persistence stage 1dosRassociated

-0.142

Amp0.2mg/mL AmpicillincellWall

0.035

Cephalexin20-100 ug/mL CephalexincellWall

-0.721

Cerulenin0.32-5 ug/mL CerulenincellWall

0.551

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.306

EMB10-20 ug/mL EthambutolcellWall

-0.411

Eta12-40 ug/mL EthionamidecellWall

-0.639

INH0.2-0.4 ug/mL IsoniazidcellWall

0.302

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.603

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.236

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.229

BZA0.12 mg/mL BenzamidearomaticAmides

0.239

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.317

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.373

H2O24 mM hydrogen peroxideDNAdamaging

-0.887

Levo10 ug/mL LevofloxacinDNAdamaging

0.192

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.397

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.125

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.380

UVUV-irradiationDNAdamaging

-0.543

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.371

Antimycin12.5-50 ug/mL Antimycin A?

-0.181

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.094

PA_110-50 ug/mL Antitubercular compound PA-1?

0.012

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.248

PA8240.2-2 ug/mL PA-824?

1.019

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.319

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.112

Verapamil50 uM Verapamil?

0.828

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.019

methoxatin10-20 ug/mL Methoxatin?